|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Arab Center For Pharmaceuticals (المركز العربي للصناعات الدوائية)
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Arab Center For Pharmaceuticals & Chemicals Industries (المركز العربي للصناعات الدوائية) Headquarters 22 King Abdullah 2 Industrial City; Sahab; Amman; 11512 |
Status: Listed Legal Form: Other non-liability limited Operational Status: Operational ISIN CODE : JO4102311019 Financial Auditors: KPMG (2010) Total Employees: 100 Tel: +962 6 4022470/2 |
|
Company Description |
| Arab Center for Pharmaceuticals and Chemicals Industries Co. is a Jordan-based company that manufactures hard hollow gelatin capsules, pharmaceuticals, medicines and veterinary drugs. It operates two factories: the capsules factory, which has an annual production capacity of 1.5 billion empty gelatin capsules, and the pharmaceuticals factory, which produces pharmaceutical products in the form of liquids, creams, ointments, tablets, suppositories, ovules, powders, aerosols and capsules. The Company | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues decreased with -24.95%, from JOD 1,282.39 thousands to JOD 962.375 thousands. The results of the period reached JOD -1,142.934 thousands at the end of the period against JOD 93.01 thousands last year. Return on equity (Net income/Total equity) went from 1.29% to -18.45%, the Return On Asset (Net income / Total Asset) went from 1.10% to -13.45% and the Net Profit Margin (Net Income/Net Sales) went from 7.25% to -118.76% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 37.15% compared to 17.14% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.32 to 3.79 when compared to the previous year. |
Key Executives |
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (non-cons) |
2010 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| Finglobe - MENA Spread Financial Statements | Finglobe - MENA Spread Financial Statements | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
8,495 |
8,459 |
| ||
Current Assets |
4,495 |
4,114 |
| ||
Total Liabilities |
2,300 |
1,237 |
| ||
Shareholders Equity |
6,194 |
7,221 |
| ||
Current Liabilities |
1,185 |
1,237 |
| ||
| * All the accounts are in JOD. | ||
Income Statement
| ||
Total Operating Revenue |
962 |
1,282 |
| ||
Operational Profit (Loss) |
105 |
|
| ||
Net Profit (Loss) |
-1,142 |
93 |
| ||
| * All the accounts are in JOD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-13.45% |
1.1% |
| ||
Annualised Return on Assets (ROA) |
-13.45% |
1.1% |
| ||
Return on Equity (ROE) |
-18.45% |
1.29% |
| ||
Annualised Return on Equity (ROE) |
-15.83% |
1.26% |
| ||
Return on Sales (ROS) |
-118.76% |
7.25% |
| ||
Return on Capital |
0% |
1.46% |
| ||
Gross Profit Margin |
203.93% |
186.76% |
| ||
Operating Profit Margin |
0% |
8.24% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
0.48x |
0.52x |
| ||
Inventory Turnover |
2.58x |
9.67x |
| ||
Current asset turnover |
0.21x |
0.31x |
| ||
Fixed-asset turnover |
0.24x |
0.30x |
| ||
Asset Turnover |
0.11x |
0.15x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
- |
105 |
| ||
EBITDA |
- |
105 |
| ||
Enterprise value |
15,249 |
12,843 |
| ||
Enterprise Value / EBITDA |
- |
121.47 |
| ||
Bookvalue (BV) |
6,194 |
7,221 |
| ||
Net Cash |
-2,299 |
-1,043 |
| Liquidity Ratios | ||
| ||
Current Ratio |
379.03% |
332.34% |
| ||
Quick ratio |
347.58% |
321.62% |
| ||
Doom's day ratio |
0.1% |
15.71% |
| Leverage Ratios | ||
| ||
Leverage ratio |
137.15% |
117.14% |
| ||
Debt to equity |
37.15% |
17.14% |
| ||
Debt to total assets |
27.09% |
14.63% |
| ||
Long Term Debt to Capital |
15.26% |
0% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
- |
111.61 |
| ||
Market Cap / Net cash |
-5.63 |
-11.31 |
| Trend Ratios | ||
| ||
Revenue Trend |
75.05% |
70.71% |
| ||
Net Income Trend |
-1,228.83% |
38.28% |
| ||
Operating Income Trend |
0% |
39.01% |
| ||
 |